Biogen Inc.

Biogen Inc.verified

BIIB

Price:

$226.46

Market Cap:

$32.97B

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; ADUHELM for the treatment of Alzheimer's disease; IMRALDI, an adalimumab biosimilar referencing HUMIRA; and FLIXABI, an infliximab biosimilar referencing REMICADE. In addition, the company offers RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of AN...[Read more]

Industry

Drug Manufacturers - General

IPO Date

1991-09-17

Stock Exchange

NASDAQ

Ticker

BIIB

The ROE as of June 2024 (TTM) for Biogen Inc. (BIIB) is 7.92%

According to Biogen Inc.’s latest financial reports and current stock price. The company's current ROE is 7.92%. This represents a change of 301.09% compared to the average of 1.97% of the last 4 quarters.

Biogen Inc. (BIIB) Historical ROE (quarterly & annually)

How has BIIB ROE performed in the past?

The mean historical ROE of Biogen Inc. over the last ten years is 27.60%. The current 7.92% ROE has changed -71.32% with respect to the historical average. Over the past ten years (40 quarters), BIIB's ROE was at its highest in in the June 2020 quarter at 13.64%. The ROE was at its lowest in in the December 2017 quarter at -2.36%.

Quarterly (TTM)
Annual

Average

27.60%

Median

28.83%

Minimum

7.85%

Maximum

44.14%

Biogen Inc. (BIIB) ROE by Quarter and Year

Discovering the peaks and valleys of Biogen Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 68.69%

Maximum Annual ROE = 44.14%

Minimum Annual Increase = -65.53%

Minimum Annual ROE = 7.85%

Quarterly (TTM)
Annual
YearROEChange
20237.85%-65.53%
202222.76%60.28%
202114.20%-62.07%
202037.44%-15.19%
201944.14%29.84%
201834.00%68.69%
201720.15%-33.98%
201630.53%-19.31%
201537.84%39.41%
201427.14%25.63%

Biogen Inc. (BIIB) Average ROE

How has BIIB ROE performed in the past?

The current ROE of Biogen Inc. (BIIB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

14.93%

5-year avg

25.28%

10-year avg

27.60%

Biogen Inc. (BIIB) ROE vs. Peers

How is BIIB’s ROE compared to its peers?

Biogen Inc.’s ROE is greater than Bristol-Myers Squibb Company (-23.01%), less than AbbVie Inc. (55.33%), less than Merck & Co., Inc. (5.84%), less than Gilead Sciences, Inc. (2.32%), less than Johnson & Johnson (53.97%), less than Amgen Inc. (58.59%), greater than Pfizer Inc. (-0.31%), less than Sanofi (9.61%), less than Novartis AG (34.58%), less than GSK plc (33.83%),

CompanyROEMarket cap
-23.01%$83.05B
55.33%$299.63B
5.84%$322.93B
2.32%$80.07B
53.97%$351.25B
58.59%$162.69B
-0.31%$152.88B
9.61%$118.50B
34.58%$205.29B
33.83%$82.91B

Build a custom stock screener for Biogen Inc. (BIIB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biogen Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Biogen Inc. (BIIB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Biogen Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Biogen Inc.'s ROE?

How is the ROE calculated for Biogen Inc. (BIIB)?

What is the highest ROE for Biogen Inc. (BIIB)?

What is the 3-year average ROE for Biogen Inc. (BIIB)?

What is the 5-year average ROE for Biogen Inc. (BIIB)?

How does the current ROE for Biogen Inc. (BIIB) compare to its historical average?